Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
26.90
+0.60 (2.28%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $93.49 million as of June 10, 2026. Its market cap has increased by 1,331.80% in one year.
Market Cap
93.49M
Enterprise Value
114.45M
1-Year Change
1,331.80%
Ranking
Category
Stock Price
$26.90
Market Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $93.49M, an increase of 237.72%. That is a compound annual growth rate of 69.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 93.49M | -2.29% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortress Biotech | 94.67M |
| Cue Biopharma | 94.67M |
| Cibus | 93.83M |
| PepGen | 93.38M |
| ImmuCell | 89.36M |
| Inovio Pharmaceuticals | 89.31M |
| PolyPid | 88.58M |
| Rein Therapeutics | 88.27M |